Reuters logo
BRIEF-Actinium Pharmaceuticals granted orphan designation from the European medicines agency for Actimab-A
May 24, 2017 / 1:27 PM / 5 months ago

BRIEF-Actinium Pharmaceuticals granted orphan designation from the European medicines agency for Actimab-A

May 24 (Reuters) - Actinium Pharmaceuticals Inc:

* Actinium Pharmaceuticals granted orphan designation from the european medicines agency for Actimab-A

* Actinium Pharmaceuticals Inc - Actimab-A is currently in a multi-center phase 2 clinical trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below